Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 1,011 | 20,890 | 30,027 | 11,247 | 60,000 |
| Gross Profit | 1,011 | 20,890 | 30,027 | 11,247 | 60,000 |
| Operating Expenses | 32,168 | 27,653 | 30,560 | 29,608 | 26,655 |
| Operating Income | -31,157 | -6,763 | -533 | -18,361 | 33,345 |
| Other Income | -1,381 | 97 | 104 | 198 | 301 |
| Pre-tax Income | -32,538 | -6,666 | -429 | -18,163 | 33,646 |
| Net Income Continuous | -32,538 | -6,666 | -429 | -18,163 | 33,646 |
| Net Income | $-32,538 | $-6,666 | $-429 | $-18,163 | $33,646 |
| EPS Basic Total Ops | -1.19 | -0.24 | -0.02 | -0.66 | 1.23 |
| EPS Basic Continuous Ops | -1.18 | -0.24 | -0.02 | -0.66 | 1.23 |
| EPS Diluted Total Ops | -1.19 | -0.24 | -0.02 | -0.66 | 1.23 |
| EPS Diluted Continuous Ops | -1.18 | -0.24 | -0.02 | -0.66 | 1.23 |
| EBITDA(a) | $-30,672 | $-5,994 | $378 | $-17,943 | $34,190 |